Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neoplasms × Tranexamic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Thromboembolism 1 Sarcoma 1 Postoperative Hemorrhage 1 Ovarian Neoplasms 1 Neoplasms 1 Menorrhagia 1 Leiomyoma 1 Hemorrhage 1 Hematologic Neoplasms 1 Breast Neoplasms 1 Bone Neoplasms 1 Blood Loss, Surgical 1

Interventions

Gemcitabine 43 Paclitaxel 41 Carboplatin 37 pembrolizumab 36 Cyclophosphamide 36 Bevacizumab 34 Fluorouracil 26 Docetaxel 26 Cisplatin 26 Nivolumab 23 Capecitabine 23 Pemetrexed 21 Oxaliplatin 19 Leucovorin 19 Irinotecan 19 Dexamethasone 19 Sorafenib 18 Ipilimumab 17 Everolimus 17 Radiotherapy 15 Erlotinib Hydrochloride 15 Doxorubicin 15 Cetuximab 14 fludarabine 13 Rituximab 13 Lapatinib 13 eribulin 12 Sunitinib 12 Prednisone 12 Fulvestrant 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01980355 2023-08-07

TXA

Corewell Health West

Phase NA Completed

76 enrolled 9 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡